Cargando…
Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosis
Recurrent respiratory papillomatosis (RRP) is a chronic and difficult to treat disease of the larynx. In 1998, the first article was published that described the use of the antiviral substance cidofovir to treat this disease. Although the results are promising, there remains some concern about the p...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Springer-Verlag
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2441494/ https://www.ncbi.nlm.nih.gov/pubmed/18458927 http://dx.doi.org/10.1007/s00405-008-0658-0 |